NCT00057798View on ClinicalTrials.gov

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

May 31, 2003

Study Completion Date

June 30, 2008

Conditions
Lung Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

vinorelbine ditartrate

GENETIC

cytogenetic analysis

GENETIC

loss of heterozygosity analysis

GENETIC

microarray analysis

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00057798 - Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery | Biotech Hunter | Biotech Hunter